Share Name Share Symbol Market Type Share ISIN Share Description
Tissue Regenix LSE:TRX London Ordinary Share GB00B5SGVL29 ORD 0.5P
  Price Change % Change Share Price Shares Traded Last Trade
  +0.00p +0.00% 7.40p 10,000 08:00:00
Bid Price Offer Price High Price Low Price Open Price
7.00p 7.80p 7.40p 7.40p 7.40p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 5.23 -10.77 -1.00 86.7

Tissue Regenix (TRX) Latest News

More Tissue Regenix News
Tissue Regenix Takeover Rumours

Tissue Regenix (TRX) Share Charts

1 Year Tissue Regenix Chart

1 Year Tissue Regenix Chart

1 Month Tissue Regenix Chart

1 Month Tissue Regenix Chart

Intraday Tissue Regenix Chart

Intraday Tissue Regenix Chart

Tissue Regenix (TRX) Discussions and Chat

Tissue Regenix Forums and Chat

Date Time Title Posts
10/11/201805:58Tissue Regenix delivering practical solutions to real clinical issues2,075
14/3/201817:13Torex - an insiders tale24
24/5/201609:30Third time lucky6,918
29/6/201320:26TOREX 2007 - THE TILLS RING AT LAST8
24/9/201209:10Torex Retailing8

Add a New Thread

Tissue Regenix (TRX) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Tissue Regenix trades in real-time

Tissue Regenix (TRX) Top Chat Posts

Tissue Regenix Daily Update: Tissue Regenix is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker TRX. The last closing price for Tissue Regenix was 7.40p.
Tissue Regenix has a 4 week average price of 7.25p and a 12 week average price of 7.25p.
The 1 year high share price is 11.75p while the 1 year low share price is currently 5.63p.
There are currently 1,171,730,823 shares in issue and the average daily traded volume is 58,140 shares. The market capitalisation of Tissue Regenix is £86,708,080.90.
robste: Today, like many other days recently, TRX was showing as over 6% down without the volume of sales to even remotely justify such a fall. Then, when the market closed, it suddenly reverted to show no changed in the share price. I've noticed this happening with other shares in my portfolio too, mostly AIM or smaller companies. Can anyone shed any light on why prices can temporarily show large drops like this, only to revert to its correct price once the market closes?
channel pirate: Quiet on here whilst we all wait for some good news to be announced. The 16988 shares showing as a "sell" at 10.975p today is actually my "BUY". Sold some of these a little while back and bought them back today £100 cheaper, not a lot I know, but sold a different share yesterday for £800 profit, so thought I would put it toward rounding up my holding here. C'mon Mr Couldwell, an update might just get the share price moving in the right direction again.
channel pirate: 2 X RNS's today !! Let's hope we get some positive share price lifting results on 19th March then: 26/02/2018 7:01am UK Regulatory (RNS & others) Tissue Regenix (LSE:TRX) Intraday Stock Chart Today : Monday 26 February 2018 Click Here for more Tissue Regenix Charts. TIDMTRX RNS Number : 8568F Tissue Regenix Group PLC 26 February 2018 Tissue Regenix Group plc Notice of Results Leeds, 26 February 2018 - Tissue Regenix Group (AIM:TRX) ("Tissue Regenix" or "The Group") the regenerative medical devices company announces it will release its unaudited preliminary results for the year ended 31 December 2017 on Monday 19 March. Further information regarding an analyst call will follow in due course. For more Information: Tissue Regenix Group plc Tel: 0330 Caitlin Pearson Head of Communications 430 3073 / 07920272 441 ---------------------------------------- ------------ Jefferies International Ltd Tel: 020 Simon Hardy / Christopher Binks 7029 8000 ---------------------------------------- ------------ FTI Consulting Tel: 0203 Brett Pollard / Mo Noonan/ Rob Winder 727 1000
channel pirate: Well the company are good at manufacturing tissue to repair / heal wounds etc, so maybe they ought to manufacture a positive RNS that will repair the share price which has been severely wounded over the past few months !!
andrewbaker: Adding to and following on from post 1934 in June, it's heartening to know that even a business that's not blessed with the best management, can become compelling when the product is really good and the share price way too low. What we really need is better figures, and better management; then this can really go. I'd buy more, but I'm already loaded to the gills, and can't destabilise my portfolio by doing so: so ... you guys drink your fill, and enjoy what should be, better late that never, a big rise northwards (and more northwards than before, too). ... Couldn't resist it: bought another 15,000 at 13.95p. I'm holding a heck of a lot more, so ok for this top-up, IMHO. lol. :)
channel pirate: With the share price having lost just over 35.36% in the last 6 months, then we could do with some good supporting news right now, or like "yesterday" and not "tomorrow". I have built a nice size holding during these past 6 months, but will not be panic selling or adding more until we get some positive news from the company.
channel pirate: Morning bamboo2, Guessing, then the new Holdings Company has been inaugurated to acquire acquisitions the Main Company has in their sights as being beneficial to the Main Company – hence the recent RNS regarding CellRight Technologies, LLC ("CellRight"). To me then this indicates the Company is getting “stronger̶1; all round and is expanding, generating more income etc, both of which has not yet been updated to the market. I would expect the large shareholders (Invesco, Woodford etc) are already briefed what is happening, especially with the share price languishing at the present low price, which must have knocked millions off the value of their holdings. I’m looking forward to the Prelims, and let’s hope it reassures us small pi’s also that we have “boarded the right train”.
channel pirate: Thought I would send an email to Investor Relations at the company this morning - will post the reply should I get one............. Good morning Caitlin, Being a shareholder with a six figure holding it is sad to see some shareholders exiting due to a falling share price and a lack of updates from the company. This time last year the company had already announced via the market of when it was going to report it’s Accounts & Report for the preceding year. Can you advise me of when we are likely to hear from the company in respect of progress and the last financial years Accounts. Thanking you in anticipation. Kind Regards,
channel pirate: Just been looking back through some of the company announcements over the last few months which re-assures me of my holding and maybe that on this dip, or subsequent dips, then it might be prudent to start adding again. From the announcement on 28th November : “The launch of OrthoPure™ XT remains on track for H1 2017, with CE mark approval in the same period. The first distribution agreements within Europe have been signed, indicators of the strong commercial and clinical support for OrthoPure™ XT, in preparation for rapid commercialisation in key European markets once approval is granted. Peter Hamer, Commercial Director TRX Orthopaedics Ltd: "We are extremely encouraged by the initial results returned from the study. Having entered our first distributor agreements, which highlight the demand and market opportunity for OrthoPure™ XT, we remain on track for launch of OrthoPure™ XT by the end of H1 2017.” So anytime in the next 4 months if all goes to plan, and that should see a significant rise in the share price if we are lucky ??
multibagger: Hi Swiss Paul, Some very valid and searching questions. The biotech/healthcare product market is a very complex one due to various procurement and payment schemes/methods. In the UK, the NHS is a slow adopter and constrained by cost.The US is a much higher cost healthcare system and if TRX finds traction there, then there will be an uplift in share price. Though I keep an eye on TRX, I am not of the view that the share price will move upwards fast and not invested currently. I'm not a fan of either Odell or Samuels having met them both in Leeds at the AGM a few years ago, when I was the only shareholder present ! I'm not convinced about their their tech pipeline either, as regenerative medicine is moving a lot quicker than TRX are. I sold out not long after. My approach to biotech investing has changed and now largely go for funds....I hold AXA Framlington Biotech though I made good money from SCLP, SUMM and SAR in the past.Cyprotex (CRX) is moving in the right direction and their R&D product delivery and commercialisation is much more attractive - I pointed it out here when it was about 60p on this board - now about 135p. I hope TRX comes good for all holders - but my take is that investors may have a fairly long wait. Good luck all :)
Tissue Regenix share price data is direct from the London Stock Exchange
add chat code
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20181118 18:09:11